Загрузка...
Iatrogenic Cushing's syndrome and osteoporosis due to an interaction between fluticasone and ritonavir
The advent of highly active antiretroviral therapy for HIV infection dramatically changed the landscape of the disease. Ritonavir, a protease inhibitor (PI) frequently used in low doses to ‘boost’ the concentrations of other PIs, inhibits the cytochrome P450 3A4 isoenzyme, a common metabolic pathway...
Сохранить в:
| Опубликовано в: : | BMJ Case Rep |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636689/ https://ncbi.nlm.nih.gov/pubmed/26516245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-211080 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|